Skip to content
PubMed This is a summary of 18 peer-reviewed journal articles Updated
Medical Genetics · Trisomy X

Are NIPT Results for Trisomy X Always Accurate? What to Know

At a Glance

NIPT is a screening test, not a diagnosis, for Trisomy X. A high-risk result does not prove the baby has 47,XXX because placental or maternal DNA and other factors can affect the result. Amniocentesis or postnatal karyotyping can provide a definitive answer.

No, Non-Invasive Prenatal Testing (NIPT) results for Trisomy X are not always accurate. If your NIPT indicates a “high risk” or “screen positive” result for Trisomy X (also known as 47, XXX), it means there is a higher chance your baby has the condition. However, it is entirely possible that your baby does not have it at all [1]. An NIPT is a screening test, not a definitive diagnosis, and professional medical reviews strongly advise against making irreversible pregnancy decisions based on this screen alone [2][3].

Screening vs. Diagnostic Testing

NIPT looks at cell-free DNA—small fragments of DNA floating in your bloodstream. This sample is actually a mixture of your own DNA and DNA from the placenta [4]. Because it is only a screening test, it flags potential risks but cannot confirm them. To know for certain whether your baby has Trisomy X, you would need a diagnostic test [2][5].

You have a few options for diagnostic testing:

  • Chorionic Villus Sampling (CVS): Done earlier in pregnancy, but because it tests the placenta, it can sometimes be confusing if the extra X chromosome is only in the placenta rather than the baby.
  • Amniocentesis: Usually the preferred prenatal test for sex chromosome screens. It tests the amniotic fluid around the baby. While it provides a definitive answer, it is an invasive procedure with a small risk of miscarriage [3][5].
  • Postnatal Karyotype: A simple blood test done after the baby is born. This avoids any procedure-related risks to the pregnancy, but it means waiting until after birth for a definitive answer [6].

How often is the NIPT wrong?

When trying to understand your results, the most helpful concept is the Positive Predictive Value (PPV). This represents the actual chance that a “high risk” screening result is truly positive for the baby [1].

It is important to know that there is no single, universal PPV for Trisomy X. Published estimates vary widely, ranging from roughly 23% to 79% [1][7][8]. The accuracy depends heavily on the specific laboratory, your age, whether you are in a high-risk group or a general screening population, and the underlying prevalence of the condition [9][1]. Because of this variation, a genetic counselor can help estimate the individualized likelihood for your specific pregnancy based on your lab report [10].

What causes a false positive?

There are several biological reasons why an NIPT might show a high risk for Trisomy X even when the baby is completely unaffected:

  • Confined Placental Mosaicism (CPM): Mosaicism means there is a mixture of cells with different chromosome patterns. Because NIPT tests placental DNA, it can detect an extra X chromosome that is only present in the placenta, while the baby’s actual cells are typical [11][12].
  • Maternal Mosaicism or Maternal Trisomy X: Because the NIPT mixes your DNA with the placental DNA, it might pick up an extra X chromosome in your own cells. Some women have an extra X chromosome in some or all of their cells without knowing it, which is one possible explanation for a false positive [4][13].
  • Vanishing Twin: Sometimes a pregnancy begins with twins, but one is lost very early on. The DNA from the lost twin can remain in your blood and affect the NIPT results [14].
  • Technical and Genomic Factors: The laboratory’s analysis can sometimes be confounded by variations in the mother’s DNA (such as copy-number variants) or other technical limitations [15].

What does this mean for the baby?

Even if diagnostic testing confirms Trisomy X, it is important to know that NIPT and chromosome tests cannot predict an individual child’s severity or outcome. Trisomy X has a very wide range of expression. Some children may have speech, language, motor, or learning differences that benefit from early intervention and monitoring, while others have typical development and no obvious symptoms [16][17]. While your doctor may recommend a detailed ultrasound to check on the baby, a normal ultrasound cannot rule Trisomy X in or out [18].

Next Steps

Receiving a high-risk result is incredibly stressful. Waiting for answers can be emotionally exhausting, and it is completely normal to seek support from a partner, trusted friend, or prenatal mental health professional during this time.

Many parents find it helpful to speak with a genetic counselor, a healthcare professional who can help you understand your specific test report and discuss your options for diagnostic testing [10]. They can help you weigh the benefits of getting a definitive answer during pregnancy against the option of waiting for postnatal testing [6].

Common questions in this guide

Can a high-risk NIPT result confirm that my baby has Trisomy X?
No. NIPT analyzes cell-free DNA from the placenta and the pregnant person's bloodstream, so it estimates risk rather than diagnosing the baby. A diagnostic test such as amniocentesis during pregnancy or a postnatal karyotype after birth is needed for confirmation.
How likely is a positive Trisomy X NIPT result to be correct?
Published estimates of the positive predictive value for Trisomy X range from about 23% to 79%, so a positive screen is not equally predictive in every pregnancy. The estimate can vary with the laboratory, maternal age, screening population, and the condition's prevalence. A genetic counselor can help interpret the specific report.
Why can NIPT show Trisomy X when the baby does not have it?
Because NIPT samples placental DNA mixed with maternal DNA, an extra X chromosome may come from the placenta or the mother rather than the baby. DNA from a vanished twin and technical or genomic factors can also affect the result.
Which test can confirm Trisomy X before birth?
Amniocentesis is usually the preferred prenatal diagnostic test for a positive sex chromosome screen because it examines cells in the amniotic fluid and can provide a definitive answer. Chorionic villus sampling can be performed earlier but tests the placenta, so placental mosaicism can make interpretation difficult. A postnatal karyotype is an option if you prefer to wait until after birth.
Can a normal ultrasound rule out Trisomy X?
No. Ultrasound may be recommended to evaluate the pregnancy, but a normal result cannot confirm or exclude Trisomy X. Chromosome testing is needed to determine whether the extra X chromosome is present.
Does a positive NIPT result predict how Trisomy X will affect my child?
No. NIPT and chromosome testing cannot predict an individual child's development or outcome. Some children have typical development, while others may have speech, language, motor, or learning differences and benefit from early intervention and monitoring.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.What does my specific laboratory report say about its own Positive Predictive Value (PPV) and the fetal fraction?
  2. 2.What are the benefits and risks of pursuing an amniocentesis now versus waiting for a postnatal blood test?
  3. 3.If an amniocentesis shows the baby does not have Trisomy X, should I consider being tested myself to see if my own genetics caused the result?
  4. 4.Would a detailed ultrasound change your medical recommendations, keeping in mind it cannot definitively rule Trisomy X out?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (18)
  1. 1

    A systematic review and meta-analysis of cell-free DNA testing for detection of fetal sex chromosome aneuploidy.

    Shear MA, Swanson K, Garg R, et al.

    Prenatal diagnosis 2023; (43(2)):133-143 doi:10.1002/pd.6298.

    PMID: 36588186
  2. 2

    Committee Opinion No. 640: Cell-Free DNA Screening For Fetal Aneuploidy.

    Obstetrics and gynecology 2015; (126(3)):e31-e37 doi:10.1097/AOG.0000000000001051.

    PMID: 26287791
  3. 3

    Predicting fetoplacental mosaicism during cfDNA-based NIPT.

    Neofytou M

    Current opinion in obstetrics & gynecology 2020; (32(2)):152-158 doi:10.1097/GCO.0000000000000610.

    PMID: 31977337
  4. 4

    Relationships among maternal monosomy X mosaicism, maternal trisomy, and discordant sex chromosome aneuploidies.

    Tang X, Du Y, Chen M, et al.

    Clinica chimica acta; international journal of clinical chemistry 2024; (554()):117770 doi:10.1016/j.cca.2024.117770.

    PMID: 38199578
  5. 5

    Maternal Plasma DNA and RNA Sequencing for Prenatal Testing.

    Tamminga S, van Maarle M, Henneman L, et al.

    Advances in clinical chemistry 2016; (74()):63-102.

    PMID: 27117661
  6. 6

    Noninvasive prenatal screening (NIPS) results for participants of the eXtraordinarY babies study: Screening, counseling, diagnosis, and discordance.

    Howell S, Davis SM, Thompson T, et al.

    Journal of genetic counseling 2023; (32(1)):250-259 doi:10.1002/jgc4.1639.

    PMID: 36204975
  7. 7

    Performance of noninvasive prenatal screening for fetal sex chromosome aneuploidies in a cohort of 116,862 pregnancies.

    Xu Y, Lou J, Qian Y, et al.

    Expert review of molecular diagnostics 2024; (24(5)):467-472 doi:10.1080/14737159.2024.2333951.

    PMID: 38526221
  8. 8

    Screening for Sex Chromosome Aneuploidy by Cell-Free DNA Testing: Patient Choice and Performance.

    Bevilacqua E, Ordóñez E, Hurtado I, et al.

    Fetal diagnosis and therapy 2018; (44(2)):98-104 doi:10.1159/000479507.

    PMID: 28848190
  9. 9

    Unique Challenges of NIPT for Sex Chromosome Aneuploidy.

    Wilkins-Haug L, Reimers R

    Clinical obstetrics and gynecology 2023; (66(3)):568-578 doi:10.1097/GRF.0000000000000804.

    PMID: 37650669
  10. 10

    Performance of prenatal cfDNA screening for sex chromosomes.

    Martin K, Dar P, MacPherson C, et al.

    Genetics in medicine : official journal of the American College of Medical Genetics 2023; (25(8)):100879 doi:10.1016/j.gim.2023.100879.

    PMID: 37154148
  11. 11

    The impact of confined placental mosaicism on prenatal cell-free DNA screening: Insights from a monocentric study of 99 cases.

    Rosenblum J, Blaumeiser B, Janssens K

    Placenta 2024; (152()):17-22 doi:10.1016/j.placenta.2024.04.012.

    PMID: 38744036
  12. 12

    Placental, maternal, fetal, and technical origins of false-positive cell-free DNA screening results.

    Raymond Y, Fernando S, Menezes M, et al.

    American journal of obstetrics and gynecology 2024; (230(4)):381-389 doi:10.1016/j.ajog.2023.11.1240.

    PMID: 38008147
  13. 13

    Fetal aneuploidy screening by non-invasive prenatal testing of maternal plasma DNA sequencing with "false negative" result due to confined placental mosaicism: A case report.

    Li X, Ju D, Shi Y, et al.

    Medicine 2020; (99(29)):e20848 doi:10.1097/MD.0000000000020848.

    PMID: 32702826
  14. 14

    Discordant NIPT result in a viable trisomy-21 pregnancy due to prolonged contribution to cfDNA by a demised trisomy-14 cotwin.

    Hochstenbach R, Elferink MG, van Zon PHA, et al.

    Clinical case reports 2018; (6(5)):788-791 doi:10.1002/ccr3.1424.

    PMID: 29744057
  15. 15

    Systematic analysis of the causes of NIPS sex chromosome aneuploidy false-positive results.

    Lyu Z, Huang C

    Molecular genetics & genomic medicine 2022; (10(7)):e1963 doi:10.1002/mgg3.1963.

    PMID: 35535634
  16. 16

    Expanding the phenotype of Triple X syndrome: A comparison of prenatal versus postnatal diagnosis.

    Wigby K, D'Epagnier C, Howell S, et al.

    American journal of medical genetics. Part A 2016; (170(11)):2870-2881 doi:10.1002/ajmg.a.37688.

    PMID: 27644018
  17. 17

    Language phenotypes in children with sex chromosome trisomies.

    Bishop DVM, Brookman-Byrne A, Gratton N, et al.

    Wellcome open research 2018; (3()):143 doi:10.12688/wellcomeopenres.14904.2.

    PMID: 30815537
  18. 18

    Diagnostic testing after positive results on cell free DNA screening: CVS or Amnio?

    Mardy AH, Norton ME

    Prenatal diagnosis 2021; (41(10)):1249-1254 doi:10.1002/pd.6021.

    PMID: 34386984

This page is for informational purposes only and does not constitute medical advice. A genetic counselor or prenatal clinician should interpret your Trisomy X NIPT report and discuss diagnostic options for your pregnancy.

Get notified when new evidence is published on Trisomy X syndrome.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.